Shenzhen Yao

Validation of an algorithm for identifying MS cases in administrative health claims datasets

William J. Culpepper, Ruth Ann Marrie, Annette Langer‐Gould et al. · Neurology · 2019 · 108 citations · Full text

Business, Biostatistics, Clinical Epidemiology +13

Comparative safety of direct oral anticoagulants and warfarin in venous thromboembolism: multicentre, population based, observational study

Min Jun, Lisa M. Lix, Madéleine Durand et al. · BMJ · 2017 · 93 citations · Full text

Medicine, Pharmacotherapy, Clinical Pharmacology +16

Disease-Modifying Drugs for Multiple Sclerosis and Association With Survival

Huah Shin Ng, Feng Zhu, Elaine Kingwell et al. · Neurology Neuroimmunology & Neuroinflammation · 2022 · 27 citations · Full text

Public Health, Biostatistics, Pharmacology +9

Adverse Events Associated With Disease-Modifying Drugs for Multiple Sclerosis

Huah Shin Ng, Feng Zhu, Yinshan Zhao et al. · Neurology · 2024 · 24 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Medication adherence in multiple sclerosis as a potential model for other chronic diseases: a population-based cohort study

Charity Evans, Ruth Ann Marrie, Shenzhen Yao et al. · BMJ Open · 2021 · 15 citations · Full text

Pharmacy, Pharmacotherapy, Clinical Pharmacology +16